TY - JOUR
T1 - Hydroxychloroquine's Early Impact on Cone Density
AU - Ueda-Consolvo, Tomoko
AU - Oiwake, Toshihiko
AU - Abe, Shinya
AU - Nakamura, Tomoko
AU - Numata, Ayaka
AU - Hayashi, Atsushi
N1 - Publisher Copyright:
© 2021 Tomoko Ueda-Consolvo et al.
PY - 2021
Y1 - 2021
N2 - Purpose. To evaluate early effects of hydroxychloroquine (HCQ) on the retina using adaptive optics (AO). Methods. This was a prospective observational single-center study of 29 eyes of 29 patients who had been treated with HCQ for the first time and followed with AO for a minimum of two years. Cone counting was performed in 4 quadrants, nasal, temporal, superior, and inferior, at 0.75 mm from the foveal center. The changes of cone density on AO, visual acuity, and foveal thickness within two years of use were analyzed. The changes of mean cone density of patients whose cumulative dose was over 200 g in 2 years were also assessed. We evaluated the correlation between cone density and cumulative dose of HCQ. Results. There was no significant decrease in cone density in the first 2 years of HCQ use. VA and foveal thickness did not show obvious change, either. Among 9 patients whose cumulative dose was over 200 g in 2 years, the mean cone density showed no significant change at 6, 12, 18, and 24 months compared with baseline (P=0.381, P=0.380, P=0.281, and P=0.534, respectively). There was no correlation between cone density and cumulative dose of HCQ at two years (Spearman's correlation coefficient, r = -0.0553, P=0.780; n = 29). Conclusion. AO showed no change in cone density in the first two years of HCQ use.
AB - Purpose. To evaluate early effects of hydroxychloroquine (HCQ) on the retina using adaptive optics (AO). Methods. This was a prospective observational single-center study of 29 eyes of 29 patients who had been treated with HCQ for the first time and followed with AO for a minimum of two years. Cone counting was performed in 4 quadrants, nasal, temporal, superior, and inferior, at 0.75 mm from the foveal center. The changes of cone density on AO, visual acuity, and foveal thickness within two years of use were analyzed. The changes of mean cone density of patients whose cumulative dose was over 200 g in 2 years were also assessed. We evaluated the correlation between cone density and cumulative dose of HCQ. Results. There was no significant decrease in cone density in the first 2 years of HCQ use. VA and foveal thickness did not show obvious change, either. Among 9 patients whose cumulative dose was over 200 g in 2 years, the mean cone density showed no significant change at 6, 12, 18, and 24 months compared with baseline (P=0.381, P=0.380, P=0.281, and P=0.534, respectively). There was no correlation between cone density and cumulative dose of HCQ at two years (Spearman's correlation coefficient, r = -0.0553, P=0.780; n = 29). Conclusion. AO showed no change in cone density in the first two years of HCQ use.
UR - http://www.scopus.com/inward/record.url?scp=85115970116&partnerID=8YFLogxK
U2 - 10.1155/2021/1389805
DO - 10.1155/2021/1389805
M3 - 学術論文
C2 - 34527374
AN - SCOPUS:85115970116
SN - 2090-004X
VL - 2021
JO - Journal of Ophthalmology
JF - Journal of Ophthalmology
M1 - 1389805
ER -